Skip to main content
Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI · Real-Time Price · USD
20.06
+0.12 (0.60%)
At close: Apr 28, 2026, 4:00 PM EDT
20.00
-0.06 (-0.30%)
After-hours: Apr 28, 2026, 4:56 PM EDT

Denali Therapeutics Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
503
Market Cap
3.18B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025---
Dec 31, 2024---
Dec 31, 2023330.53M222.07M204.74%
Dec 31, 2022108.46M59.80M122.90%
Dec 31, 202148.66M-287.00M-85.50%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Arcutis Biotherapeutics 376.07M
Arcus Biosciences 247.00M
Beam Therapeutics 139.74M
Tango Therapeutics 62.38M
Alumis 24.05M
NewAmsterdam Pharma Company 22.50M
Revenue Rankings

DNLI News

More News